{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:26:16Z","timestamp":1783599976425,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05264-4","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:50:06Z","timestamp":1783597806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum sclerostin in biopsy-proven glomerulonephritis primarily reflects kidney function: a cross-sectional case\u2013control study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1152-5393","authenticated-orcid":false,"given":"Oktay","family":"Ba\u011fdato\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Uluba\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra F\u0131rat","family":"O\u011fuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Emin","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simge Bardak","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine \u015eebnem","family":"Karakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"7","key":"5264_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41577-022-00816-y","volume":"23","author":"HJ Anders","year":"2023","unstructured":"Anders HJ, Kitching AR, Leung N, Romagnani P (2023) Glomerulonephritis: immunopathogenesis and immunotherapy. Nat Rev Immunol 23(7):453\u2013471","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 4","key":"5264_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/nep.13146","volume":"22","author":"PKT Li","year":"2017","unstructured":"Li PKT, Ma TKW (2017) Global impact of nephropathies. Nephrology (Carlton) 22(Suppl 4):9\u201313","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"5264_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ekir.2016.06.005","volume":"1","author":"AS Bomback","year":"2016","unstructured":"Bomback AS, Markowitz GS, Appel GB (2016) Complement-mediated glomerular diseases: a tale of 3 pathways. Kidney Int Rep 1(3):148\u2013155","journal-title":"Kidney Int Rep"},{"issue":"2","key":"5264_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0272-6386(12)80971-1","volume":"23","author":"WG Couser","year":"1994","unstructured":"Couser WG, Johnson RJ (1994) Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis 23(2):193\u2013198","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5264_CR5","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2486567","volume":"47","author":"W Zou","year":"2025","unstructured":"Zou W, Liu Y, Xu B et al (2025) Global glomerulosclerosis proportions predict nephropathy progression in IgA nephropathy: a multicenter retrospective analysis with propensity score matching. Ren Fail 47(1):2486567","journal-title":"Ren Fail"},{"issue":"1","key":"5264_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4183\/aeb.2018.90","volume":"14","author":"D Grigorie","year":"2018","unstructured":"Grigorie D, Lerner UH (2018) The crucial role of the Wnt system in bone remodelling. Acta Endocrinol (Buchar) 14(1):90\u2013101","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"3","key":"5264_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2741\/4214","volume":"19","author":"Y Wang","year":"2014","unstructured":"Wang Y, Li YP, Paulson C et al (2014) Wnt and the Wnt signaling pathway in bone development and disease. Front Biosci 19(3):379\u2013407","journal-title":"Front Biosci"},{"issue":"1","key":"5264_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1210\/jc.2013-2786","volume":"99","author":"D Cejka","year":"2014","unstructured":"Cejka D, Marculescu R, Kozakowski N et al (2014) Renal elimination of sclerostin increases with declining kidney function. J Clin Endocrinol Metab 99(1):248\u2013255","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"5264_CR9","doi-asserted-by":"publisher","first-page":"E1854","DOI":"10.1210\/jc.2014-2042","volume":"99","author":"M Kanbay","year":"2014","unstructured":"Kanbay M, Siriopol D, Saglam M et al (2014) Serum sclerostin and adverse outcomes in nondialyzed CKD patients. J Clin Endocrinol Metab 99(10):E1854\u2013E1861","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5264_CR10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2215\/CJN.07670712","volume":"8","author":"S Pelletier","year":"2013","unstructured":"Pelletier S, Dubourg L, Carlier MC, Hadj-Aissa A, Fouque D (2013) The relation between renal function and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol 8(5):819\u2013823","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"5264_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jbmr.217","volume":"26","author":"UI M\u00f6dder","year":"2011","unstructured":"M\u00f6dder UI, Hoey KA, Amin S et al (2011) Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res 26(2):373\u2013379","journal-title":"J Bone Miner Res"},{"issue":"9","key":"5264_CR12","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1681\/ASN.2009010019","volume":"20","author":"C Dai","year":"2009","unstructured":"Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, Liu Y (2009) Wnt\/\u03b2-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20(9):1997\u20132008","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5264_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3892\/etm.2021.10169","volume":"22","author":"Z Dong","year":"2021","unstructured":"Dong Z, Dai H, Gao Y et al (2021) Inhibition of the Wnt\/\u03b2-catenin signaling pathway reduces autophagy levels in complement treated podocytes. Exp Ther Med 22(1):737","journal-title":"Exp Ther Med"},{"key":"5264_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bone.2017.11.015","volume":"107","author":"N Kaesler","year":"2018","unstructured":"Kaesler N, Verhulst A, De Mar\u00e9 A et al (2018) Sclerostin deficiency modifies the development of CKD-MBD in mice. Bone 107:115\u2013123","journal-title":"Bone"},{"issue":"1","key":"5264_CR15","doi-asserted-by":"publisher","first-page":"2186151","DOI":"10.1080\/0886022X.2023.2186151","volume":"45","author":"Y Lin","year":"2023","unstructured":"Lin Y, Mao L, Chen S, Zhou C (2023) Serum sclerostin in vascular calcification in CKD: a meta-analysis. Ren Fail 45(1):2186151","journal-title":"Ren Fail"},{"key":"5264_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103762","volume":"85","author":"RY Han","year":"2025","unstructured":"Han RY, Tan RZ, Xu LH et al (2025) Activation of sclerostin inhibits Isg20-mediated aerobic glycolysis ameliorating renal fibrosis: the renoprotective mechanism of hederagenin in CKD. Redox Biol 85:103762","journal-title":"Redox Biol"},{"issue":"5","key":"5264_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/jcp.24487","volume":"229","author":"K Baek","year":"2014","unstructured":"Baek K, Hwang HR, Park HJ et al (2014) TNF-\u03b1 upregulates sclerostin expression in obese mice fed a high-fat diet. J Cell Physiol 229(5):640\u2013650","journal-title":"J Cell Physiol"},{"issue":"12","key":"5264_CR18","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.3390\/jcm8122027","volume":"8","author":"A De Mar\u00e9","year":"2019","unstructured":"De Mar\u00e9 A, Verhulst A, Cavalier E et al (2019) Clinical inference of serum and bone sclerostin levels in patients with end-stage kidney disease. J Clin Med 8(12):2027","journal-title":"J Clin Med"},{"issue":"5","key":"5264_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5414\/CN111111","volume":"99","author":"F Lima","year":"2023","unstructured":"Lima F, Monier-Faugere MC, Mawad H, David V, Malluche HH (2023) FGF-23 and sclerostin in serum and bone of CKD patients. Clin Nephrol 99(5):209\u2013218","journal-title":"Clin Nephrol"},{"issue":"24","key":"5264_CR20","first-page":"8822","volume":"22","author":"YQ Ji","year":"2018","unstructured":"Ji YQ, Guan LN, Yu SX et al (2018) Serum sclerostin as a potential novel biomarker for heart valve calcification in patients with CKD. Eur Rev Med Pharmacol Sci 22(24):8822\u20138829","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"5264_CR21","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20230239","volume":"69","author":"H Ozer","year":"2023","unstructured":"Ozer H, Baloglu \u0130, Aykut T et al (2023) Sclerostin and TNF-related weak inducer of apoptosis: can they be important in patients with glomerulonephritis? Rev Assoc Med Bras 69(7):e20230239","journal-title":"Rev Assoc Med Bras"},{"issue":"4","key":"5264_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/RHU.0000000000001256","volume":"27","author":"A Fayed","year":"2021","unstructured":"Fayed A, Soliman A, Elgohary R (2021) Measuring serum sclerostin in Egyptian patients with SLE and evaluating its effect on disease activity: a case-control study. J Clin Rheumatol 27(4):161\u2013167","journal-title":"J Clin Rheumatol"},{"key":"5264_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1177829","volume":"14","author":"A Aguilar","year":"2023","unstructured":"Aguilar A, Gifre L, Ure\u00f1a-Torres P et al (2023) Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis. Front Physiol 14:1177829","journal-title":"Front Physiol"},{"issue":"1","key":"5264_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","volume":"34","author":"D Davalos","year":"2012","unstructured":"Davalos D, Akassoglou K (2012) Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol 34(1):43\u201362","journal-title":"Semin Immunopathol"},{"issue":"7","key":"5264_CR25","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1161\/ATVBAHA.122.317635","volume":"42","author":"J Golledge","year":"2022","unstructured":"Golledge J, Thanigaimani S (2022) Role of sclerostin in cardiovascular disease. Arterioscler Thromb Vasc Biol 42(7):e187\u2013e202","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"5264_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11070428","volume":"11","author":"A De Mar\u00e9","year":"2019","unstructured":"De Mar\u00e9 A, Maudsley S, Azmi A et al (2019) Sclerostin as regulatory molecule in vascular media calcification and the bone\u2013vascular axis. Toxins (Basel) 11(7):428","journal-title":"Toxins (Basel)"},{"issue":"13","key":"5264_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134779","volume":"21","author":"A Catalano","year":"2020","unstructured":"Catalano A, Bellone F, Morabito N, Corica F (2020) Sclerostin and vascular pathophysiology. Int J Mol Sci 21(13):4779","journal-title":"Int J Mol Sci"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05264-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05264-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05264-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:50:07Z","timestamp":1783597807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05264-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":27,"alternative-id":["5264"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05264-4","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of Ankara Bilkent City Hospital (Approval No: TABED 1\u201324-462; 11\/09\/2024). The research was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors and participants provided consent for the publication of this manuscript. The authors affirm that human research participants provided informed consent for publication of anonymised data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors used an artificial intelligence (AI) based large language model tool solely to assist with language editing and to improve the readability of the manuscript. No AI tool was used to generate, analyse or interpret study data, to produce scientific content or conclusions, or to create or alter figures or tables. The authors reviewed and edited all AI-assisted text and take full responsibility for the integrity and content of the published work. No AI tool is listed as an author, in accordance with the journal\u2019s authorship and publishing-ethics policies.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI usage"}}]}}